Conditions: Epilepsy
Keywords: Keppra XR Levetiracetam XR long term partial seizures
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 190
Healthy volunteers: no

Brief summary:
To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.

Detailed description:

Arms:
arm 1: 1000 - 3000 mg/day Keppra XR (Levetiracetam XR), flexible dosing, throughout the duration of the study (planned: approximately 6 months-3 years)

Interventions: intervention 1: Keppra XR (Levetiracetam XR)
Intervention descriptions: intervention 1: 500 mg tablets, 1000 - 3000 mg/day, flexible dosing for duration of the study (planned: approximately 6 months-3 years).

Protocol document: